Curegenix
Burlingame
About Curegenix
Curegenix is a medication research firm in the clinical stage. It focused on the development of new small-molecule chemical drugs for the treatment of tumors and organ fibrosis. They are developing novel drugs targeting the WNT signaling pathway for cancer and tissue repair and regeneration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Apr 2016)
- Website: curegenix.com
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/curegenix-2617868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.